Compare WDH & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WDH | DRTS |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 669.1M | 607.1M |
| IPO Year | 2021 | N/A |
| Metric | WDH | DRTS |
|---|---|---|
| Price | $1.77 | $7.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 308.8K | ★ 361.4K |
| Earning Date | 03-11-2026 | 03-11-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ 75.20 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $456,980,701.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.60 | N/A |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | ★ 18.55 | N/A |
| 52 Week Low | $1.10 | $2.30 |
| 52 Week High | $2.18 | $7.89 |
| Indicator | WDH | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 55.18 |
| Support Level | $1.71 | $7.00 |
| Resistance Level | $1.84 | $7.77 |
| Average True Range (ATR) | 0.07 | 0.55 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 52.08 | 58.23 |
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.